219 related articles for article (PubMed ID: 26564988)
1. NUR77 exerts a protective effect against inflammatory bowel disease by negatively regulating the TRAF6/TLR-IL-1R signalling axis.
Wu H; Li XM; Wang JR; Gan WJ; Jiang FQ; Liu Y; Zhang XD; He XS; Zhao YY; Lu XX; Guo YB; Zhang XK; Li JM
J Pathol; 2016 Feb; 238(3):457-69. PubMed ID: 26564988
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Nuclear Receptor Nur77 Aggravates Mouse Experimental Colitis by Increased NFκB Activity in Macrophages.
Hamers AA; van Dam L; Teixeira Duarte JM; Vos M; Marinković G; van Tiel CM; Meijer SL; van Stalborch AM; Huveneers S; Te Velde AA; de Jonge WJ; de Vries CJ
PLoS One; 2015; 10(8):e0133598. PubMed ID: 26241646
[TBL] [Abstract][Full Text] [Related]
3. TLR-independent anti-inflammatory function of intestinal epithelial TRAF6 signalling prevents DSS-induced colitis in mice.
Vlantis K; Polykratis A; Welz PS; van Loo G; Pasparakis M; Wullaert A
Gut; 2016 Jun; 65(6):935-43. PubMed ID: 25761602
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of key regulators of Toll-like receptors in ulcerative colitis and Crohn's disease: a role for Tollip and peroxisome proliferator-activated receptor gamma?
Fernandes P; MacSharry J; Darby T; Fanning A; Shanahan F; Houston A; Brint E
Clin Exp Immunol; 2016 Mar; 183(3):358-68. PubMed ID: 26462859
[TBL] [Abstract][Full Text] [Related]
5. Nur77-mediated TRAF6 signalling protects against LPS-induced sepsis in mice.
Li XM; Zhang S; He XS; Guo PD; Lu XX; Wang JR; Li JM; Wu H
J Inflamm (Lond); 2016; 13():4. PubMed ID: 26839514
[TBL] [Abstract][Full Text] [Related]
6. Association of interleukin-1 receptor-associated kinase M (IRAK-M) and inflammatory bowel diseases.
Weersma RK; Oostenbrug LE; Nolte IM; Van Der Steege G; Oosterom E; Van Dullemen HM; Kleibeuker JH; Dijkstra G
Scand J Gastroenterol; 2007 Jul; 42(7):827-33. PubMed ID: 17558906
[TBL] [Abstract][Full Text] [Related]
7. GPA peptide enhances Nur77 expression in intestinal epithelial cells to exert a protective effect against DSS-induced colitis.
Deng Z; Zheng L; Xie X; Wei H; Peng J
FASEB J; 2020 Nov; 34(11):15364-15378. PubMed ID: 32978839
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
[TBL] [Abstract][Full Text] [Related]
9. Glutaredoxin-1 regulates TRAF6 activation and the IL-1 receptor/TLR4 signalling.
Chantzoura E; Prinarakis E; Panagopoulos D; Mosialos G; Spyrou G
Biochem Biophys Res Commun; 2010 Dec; 403(3-4):335-9. PubMed ID: 21078302
[TBL] [Abstract][Full Text] [Related]
10. Screening of tumor necrosis factor receptor-associated factor 6 as a candidate gene for inflammatory bowel disease.
Lappalainen M; Paavola-Sakki P; Halme L; Turunen U; Heliö T; Färkkilä M; Kontula K
Scand J Gastroenterol; 2006 Apr; 41(4):424-9. PubMed ID: 16635910
[TBL] [Abstract][Full Text] [Related]
11. GPA Peptide-Induced Nur77 Localization at Mitochondria Inhibits Inflammation and Oxidative Stress through Activating Autophagy in the Intestine.
Deng Z; Liu Q; Wang M; Wei HK; Peng J
Oxid Med Cell Longev; 2020; 2020():4964202. PubMed ID: 32904539
[TBL] [Abstract][Full Text] [Related]
12. Association between variants of PRDM1 and NDP52 and Crohn's disease, based on exome sequencing and functional studies.
Ellinghaus D; Zhang H; Zeissig S; Lipinski S; Till A; Jiang T; Stade B; Bromberg Y; Ellinghaus E; Keller A; Rivas MA; Skieceviciene J; Doncheva NT; Liu X; Liu Q; Jiang F; Forster M; Mayr G; Albrecht M; Häsler R; Boehm BO; Goodall J; Berzuini CR; Lee J; Andersen V; Vogel U; Kupcinskas L; Kayser M; Krawczak M; Nikolaus S; Weersma RK; Ponsioen CY; Sans M; Wijmenga C; Strachan DP; McArdle WL; Vermeire S; Rutgeerts P; Sanderson JD; Mathew CG; Vatn MH; Wang J; Nöthen MM; Duerr RH; Büning C; Brand S; Glas J; Winkelmann J; Illig T; Latiano A; Annese V; Halfvarson J; D'Amato M; Daly MJ; Nothnagel M; Karlsen TH; Subramani S; Rosenstiel P; Schreiber S; Parkes M; Franke A
Gastroenterology; 2013 Aug; 145(2):339-47. PubMed ID: 23624108
[TBL] [Abstract][Full Text] [Related]
13. The genetics of Crohn's disease and ulcerative colitis--status quo and beyond.
Ellinghaus D; Bethune J; Petersen BS; Franke A
Scand J Gastroenterol; 2015 Jan; 50(1):13-23. PubMed ID: 25523552
[TBL] [Abstract][Full Text] [Related]
14. Effects of haptoglobin polymorphisms and deficiency on susceptibility to inflammatory bowel disease and on severity of murine colitis.
Márquez L; Shen C; Cleynen I; De Hertogh G; Van Steen K; Machiels K; Perrier C; Ballet V; Organe S; Ferrante M; Henckaerts L; Galicia G; Rutgeerts P; Ceuppens JL; Vermeire S
Gut; 2012 Apr; 61(4):528-34. PubMed ID: 21708824
[TBL] [Abstract][Full Text] [Related]
15. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
Dong L; Li J; Liu Y; Yue W; Luo X
J Gastroenterol Hepatol; 2012 Jan; 27(1):110-9. PubMed ID: 21722182
[TBL] [Abstract][Full Text] [Related]
16. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population.
Glas J; Konrad A; Schmechel S; Dambacher J; Seiderer J; Schroff F; Wetzke M; Roeske D; Török HP; Tonenchi L; Pfennig S; Haller D; Griga T; Klein W; Epplen JT; Folwaczny C; Lohse P; Göke B; Ochsenkühn T; Mussack T; Folwaczny M; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2008 Mar; 103(3):682-91. PubMed ID: 18162085
[TBL] [Abstract][Full Text] [Related]
17. Syntenin negatively regulates TRAF6-mediated IL-1R/TLR4 signaling.
Chen F; Du Y; Zhang Z; Chen G; Zhang M; Shu HB; Zhai Z; Chen D
Cell Signal; 2008 Apr; 20(4):666-74. PubMed ID: 18234474
[TBL] [Abstract][Full Text] [Related]
18. Epistasis between Toll-like receptor-9 polymorphisms and variants in NOD2 and IL23R modulates susceptibility to Crohn's disease.
Török HP; Glas J; Endres I; Tonenchi L; Teshome MY; Wetzke M; Klein W; Lohse P; Ochsenkühn T; Folwaczny M; Göke B; Folwaczny C; Müller-Myhsok B; Brand S
Am J Gastroenterol; 2009 Jul; 104(7):1723-33. PubMed ID: 19455129
[TBL] [Abstract][Full Text] [Related]
19. Single nucleotide polymorphisms in C-type lectin genes, clustered in the IBD2 and IBD6 susceptibility loci, may play a role in the pathogenesis of inflammatory bowel diseases.
Wolfkamp SC; Verstege MI; Vogels EW; Meisner S; Verseijden C; Stokkers PC; te Velde AA
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):965-70. PubMed ID: 22664939
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome proliferator-activated receptor γ 2 mutation may cause a subset of ulcerative colitis.
Aoyagi Y; Nagata S; Kudo T; Fujii T; Wada M; Chiba Y; Ohtsuka Y; Yamashiro Y; Shimizu T; Ohkusa T
Pediatr Int; 2010 Oct; 52(5):729-34. PubMed ID: 20591056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
